Our awards

Johnson & Johnson Innovative Medicine Ireland has been honoured once again as Pharma Company of the Year – Large and received the Communications Award for our “Talking Depression” campaign, already recognised across Europe, at the 2024 Pharma Industry Awards.

Winning Pharma Company of the Year for the second consecutive year underscores our dedication to innovation and excellence, setting new standards in healthcare solutions and patient care at our Ringaskiddy facility.

Johnson & Johnson Innovative Medicine was recognised for our exceptional work in advancing healthcare and won three prestigious awards: Company of the Year – Large, Digital Transformation Award, and Overall Excellence in Life Sciences Award.

These awards highlight our commitment to innovation, cutting-edge research, and patient-centric solutions, driving meaningful change in Ireland’s life sciences sector.

Our “Talking Depression” campaign was honoured with the SABRE EMEA Award in the Ireland category, reflecting our efforts to raise awareness and support for people living with depression.

This recognition is a testament to our strategic creativity and dedication to enhancing patient care through impactful communication.

Johnson & Johnson Innovative Medicine was awarded Pharma Industry Company of the Year, Biotech Company of the Year, Pharma Project of the Year – Large, and Engineering Project of the Year at the 2023 Pharma Awards.

These accolades reflect our ongoing commitment to innovation and excellence in the pharmaceutical sector, helping to drive the future of healthcare.

Our “Talking Depression” campaign received the prestigious European Excellence Award in the UK and Ireland category.

This award recognises our outstanding achievements in communications, underscoring our commitment to improving mental health awareness.

We proudly won the Patient Education Project of the Year Award at the Irish Healthcare Awards for our “Talking Depression” campaign.

This award reflects our dedication to supporting open conversations about depression and improving the quality of life for patients in Ireland.

Johnson & Johnson Innovative Medicine Ireland won the Communications Award for the “PsO Let’s Talk Psoriasis” video and podcast series at the 2022 Pharma Industry Awards.

This recognition reflects our commitment to supporting and empowering patients living with psoriasis and psoriatic arthritis as they await access to specialist care.

Our Ringaskiddy site was named Facility of the Year for Project Execution for the BioCork2 – Large Scale Fed Batch Facility at the 2021 ISPE Annual Meeting.

The award recognises our commitment to safety, compliance, and efficiency in completing this significant project, even in the face of the global pandemic. It was also named the Overall Winner of the competition.

Our pharmaceutical facility in Ringaskiddy, Cork was designated as an Industry 4.0 Lighthouse by the World Economic Forum, recognising our leadership in advanced manufacturing technologies.

This prestigious honour highlights our commitment to operational excellence and sustainability.

We became the first pharmaceutical manufacturing company in Ireland to receive the Business Working Responsibly Mark in 2016.

This award acknowledges our commitment to sustainability and responsible business practices in all aspects of our operations.